Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment

por Simon, T A, Smitten, A L, Franklin, J, Askling, J, Lacaille, D, Wolfe, F, Hochberg, M C, Qi, K, Suissa, S
Publicado 2009

Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on...

por Karsdal, M.A., Tambiah, J., Hochberg, M.C., Ladel, C., Bay-Jensen, A.C., Arendt-Nielsen, L., Mobasheri, A., Kraus, V.B.
Publicado 2022

Experimental quantum speed-up in reinforcement learning agents

por Saggio, V., Asenbeck, B. E., Hamann, A., Strömberg, T., Schiansky, P., Dunjko, V., Friis, N., Harris, N. C., Hochberg, M., Englund, D., Wölk, S., Briegel, H. J., Walther, P.
Publicado 2021

A 2-year evaluation of disease progression by quantitative magnetic resonance imaging in a large primary osteoarthritic patient population

por Raynauld, J-P, Martel-Pelletier, J, Berthiaume, M-J, Beaudoin, G, Labonté, F, Bloch, DA, Choquette, D, Haraoui, B, Altman, RD, Hochberg, M, Beary, J, Cline, G, Meyer, J, Valent, DJ, Pelletier, J-P
Publicado 2004